NCT05735366 A Phase 1 Study of SAIL66 in Patients With CLDN6-positive Locally Advanced or Metastatic Solid Tumors Status COMPLETED Phase PHASE1
NCT05735080 Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer Status RECRUITING Phase PHASE1/PHASE2
NCT05729399 Clinical Study of Autologous Tumor-infiltrating Lymphocyte Injection (GT201) for Advanced Solid Tumors Status TERMINATED Phase PHASE1/PHASE2
NCT05724732 Exploratory Clinical Study of Autologous Tumor-infiltrating Lymphocyte Injection (GT201) for Advanced Gynecologic Tumors Status UNKNOWN Phase EARLY_PHASE1
NCT05717348 A Study of ES014 in Patients With Locally Advanced or Metastatic Solid Tumours Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05716919 Multiple Ascending Dose Study of CG200745 'Ivaltinostat' Oral Capsule Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05708950 A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101) Status UNKNOWN Phase PHASE1/PHASE2
NCT05708924 MT2021-27 FT538 Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer Status TERMINATED Phase PHASE1
NCT05707676 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of LB4330 in Patients With Advanced Solid Tumors(MEETCD8-001) Status TERMINATED Phase PHASE1
NCT05707325 Safety, Tolerability and Preliminary Efficacy of Engineered Red Blood Cell in Patients With Advanced Malignancies Status RECRUITING Phase EARLY_PHASE1
NCT05704985 Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05702424 Evaluation of IGM-7354 in Adults With Relapsed and/or Refractory Cancer Status COMPLETED Phase PHASE1
NCT05701306 APG-115 Alone or in Combination With APG-2575 in Children With Recurrent or Refractory Neuroblastoma or Solid Tumors Status RECRUITING Phase PHASE1
NCT05691608 MoleculAr Profiling for Pediatric and Young Adult Cancer Treatment Stratification 2 Status RECRUITING Phase NA
NCT05678010 A Study of AZD1390 and Stereotactic Body Radiotherapy (SBRT) for People With Metastatic Solid Tumor Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05672459 A Safety And Efficacy Study Of HLA-G- Targeted CAR-T Cells IVS-3001 In Subjects With Previously Treated Advanced HLA-G-Positive Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT05661201 NEROFE and Doxorubicin in KRAS-mutated ST2-positive Solid Tumors Status RECRUITING Phase PHASE1